← Back to catalogue

Rapid Response

FDA UDI

Class II (US FDA UDI)

by BTNX Inc

Identity

Trade Name
Rapid Response FDA UDI
Generic Name
Cotinine IVD, kit, rapid ICT, clinical FDA UDI
Device Name
Rapid Response Saliva Drug Test (COT/THC) - THC40, COT30 FDA UDI
Model / Reference
D2.12-2FC1 FDA UDI
Description
Rapid Response Saliva Drug Test (COT/THC) - THC40, COT30 FDA UDI

Identifiers

Primary DI / UDI-DI
10722066008369 FDA UDI
510(k) Number
K223162 FDA UDI
FDA Product Code
LDJ FDA UDI
MKU FDA UDI
GMDN Term
Cotinine IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3870 FDA UDI
862.3220 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cotinine IVD, kit, rapid ICT, clinical

Rapid Response by BTNX Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cotinine IVD, kit, rapid ICT, clinical.

Cleared under the same submission

K223162 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
BTNX Inc

Sources (1)

  • FDA UDI ed89b6a1-8178-43ef-9f40-96e9764e6a25 34 fields · synced May 30, 2026